BIOL

Biolase, Inc.
BIOL

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

BIOL was delisted on the 18th of June, 2024.

Back to rankings

18 hedge funds and large institutions have $7.28M invested in Biolase, Inc. in 2018 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
18
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$410K
2
+$32.1K
3
+$13K
4
Citadel Advisors
Citadel Advisors
Florida
+$13K
5
TSS
Two Sigma Securities
New York
+$12K

Top Sellers

1
-$245K
2
-$83K
3
-$27K
4
TFO
Tarbox Family Office
California
-$8K
5
Northern Trust
Northern Trust
Illinois
-$2.58K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$6.11M
2
$410K
3
$287K
4
$143K
5
$125K
6
$44K
7
$33K
8
$31K
9
$22K
10
$13K
11
$13K
12
$12K
13
$11K
14
$10K
15
$8K
16
$4K
17
$2K
18
$1K
19
$1K
20
$400
21
–
22
–